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Summary
A range of Streptococcus bacteria are able to interact with blood platelets to form a thrombus
(clot). Streptococcus gordonii is ubiquitous within the human oral cavity and amongst the common
pathogens isolated from subjects with infective endocarditis. Two cell surface proteins, Hsa and
Platelet adherence protein A (PadA), in S. gordonii mediate adherence and activation of platelets.
In this study, we demonstrate that PadA binds activated platelets and that an NGR (Asparagine‐
Glycine‐Arginine) motif within a 657 amino acid residue N‐terminal fragment of PadA is
responsible for this, together with two other integrin‐like recognition motifs RGT and AGD. PadA
also acts in concert with Hsa to mediate binding of S. gordonii to cellular fibronectin and
vitronectin, and to promote formation of biofilms. Evidence is presented that PadA and Hsa are
each reliant on the other's active presentation on the bacterial cell surface, suggesting
cooperativity in functions impacting both colonization and pathogenesis.
1 | INTRODUCTION
Streptococcus, Staphylococcus, and Enterococcus bacteria account for
>80% cases of infective endocarditis (Muñoz et al., 2015; Slipczuk
et al., 2013) and are able to trigger activation or aggregation of blood
platelets into a clot or thrombus (Fitzgerald, Foster, & Cox, 2006;
Kerrigan, 2015). Viridans‐group streptococci that enter the blood-
stream in otherwise healthy subjects almost always originate from
the complex microbial communities present within the human oral
cavity (Cahill & Prendergast, 2015; McNicol & Israels, 2010; Nilson,
Olaison, & Rasmussen, 2015). Accordingly, there is a predictive link
between levels of oral hygiene and the risk of cardiovascular disease
(Lockhart et al., 2009). Platelet adhesion and activation by oral strep-
tococci occurs by several different mechanisms (Cognasse et al.,
2015; Kerrigan & Cox, 2010; McNicol, 2015). For Streptococcus
gordonii, S. oralis and S. sanguinis, a common primary interaction
occurs with platelet integrin receptor GPIb mediated by a bacterial
surface serine‐rich repeat protein (Deng et al., 2014). In S. sanguinis,
a direct interaction between serine‐rich repeat protein SrpA and
GPIbα leads to platelet rolling over immobilized bacteria and adhe-
sion at low shear (Kerrigan et al., 2002; Plummer et al., 2005).
S. gordonii serine‐rich repeat glycoprotein designated Hsa (Takahashi,
Konishi, Cisar, & Yoshikawa, 2002), or GspB (Bensing & Sullam,
2002), seems to act in a similar manner (Bensing, López, & Sullam,
2004; Kerrigan et al., 2007). Hsa and GspB recognize structur-
ally‐distinct sialic acid‐oligosaccharides on GPIb (Takamatsu et al.,
2005). Once engaged with the streptococci the platelets become acti-
vated, spread, aggregate, and initiate thrombus formation, under which
conditions, the bacteria are well protected from host immune defences
and antibiotics (Jenne & Kubes, 2015; Jung et al., 2015).
The mechanisms by which platelets are activated by streptococci
following adhesion are poorly understood. Recent work has identified
the importance of specific antibodies in bacterial activation of platelets
through receptor FcγRIIa (Arman et al., 2014; Pampolina & McNicol,
2005; Tilley et al., 2013). In S. gordonii, a ubiquitous human oral bacte-
rium, there is direct activation of FcγRIIa integrin (non‐antibody medi-
ated), and then inside‐out activation of the most highly‐expressed
platelet receptor GPIIbIIIa (αIIbβ3) (Keane et al., 2010). Further activa-
tion is associated with secretion of granules and secondary mediators,†UCL Eastman Dental Institute, 256 Gray's Inn Rd, London WC1X 8LD.
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filopodia formation (spreading), generation of ADP and thromboxane
A2 (TxA2) to reinforce αIIbβ3 activation (Cox, Kerrigan, & Watson,
2011), and then aggregation with nearby‐activated platelets via fibrin-
ogen (Moriarty et al., 2015).
We have identified a protein designated Platelet adherence pro-
tein A (PadA), that is expressed on the surface of S. gordonii, and which
interacts directly with platelets (Petersen et al., 2010). PadA precursor
(3,646 amino acid [aa] residues) comprises a N‐terminal region of
1,328 aa residues containing a von Willebrand Factor (vWF)‐like
domain (aa residues 72–229), and a C‐terminal region comprising 14
blocks of aa residue repeats (Petersen et al., 2010) with a bacterial cell
wall anchor region and sortase (LPxTG) motif (Mazmanian, Ton‐That, &
Schneewind, 2001) (see Figure 1). PadA, unlike Hsa, does not interact
with sialylated GPIb (Petersen et al., 2010), but was shown to bind
directly to the platelet receptor αIIbβ3 over‐expressed on the surface
of Chinese hamster ovary cells (Petersen et al., 2010). Binding of PadA
to αIIbβ3 on platelets results in platelet activation; however, it is not
known if PadA is able to activate platelets on its own, or if it requires
a coactivator. Previous results suggest that αIIbβ3 may bind to
S. gordonii via common integrin‐recognition motifs (RGT and AGD)
present within the N‐terminal region of PadA (Keane et al., 2013).
Recently, it has emerged that another motif, NGR (Asn‐Gly‐Arg), found
in the D domain of fibrinogen on each of the β and γ chains, plays an
important role in the interaction of αIIbβ3 with fibrinogen (Moriarty et
al., 2015). A similar motif is found within the N‐terminal region of
PadA, raising the possibility that this might be a key factor in recogni-
tion of αIIbβ3 by PadA.
In this article, we have investigated the relative functions of Hsa
and PadA in S. gordonii platelet interactions, and in bacterial cell
binding to various extracellular matrix components that may be
exposed at sites of endothelial damage, for example, fibronectin or
vitronectin. We have also studied in more detail the interactions of
the mature N‐terminal F2 region (657 aa residues) of PadA with
platelets and matrix components, and more specifically the relative
roles of the integrin‐recognition motifs and NGR in S. gordonii host
interactions.
2 | RESULTS
2.1 | Expression of padA and hsa in deletion mutants
and complemented strains
A diagrammatic representation of PadA protein is presented in
Figure 1 together with a visual expansion of the 690 aa‐residue
precursor N‐terminal domain (F2) of main focus in this paper, and the
corresponding aa sequence. Three integrin‐like recognition motifs
within the F2 domain are highlighted. To investigate further the
functional properties of the PadA protein, the entire coding region
was cloned into replicative plasmid vector pMSP downstream of a
nisin‐inducible promoter (see 4). The hsa gene was cloned in the same
way as previously described (Jakubovics, Brittan, Dutton, & Jenkinson,
2009). Because Hsa is glycosylated by various products encoded
by genes within the hsa‐accessory secretion system locus (Zhou
& Wu, 2009), authentic Hsa protein has not been expressed in a
surrogate host bacterium. The results obtained from PadA Western
immunoblot analyses of mutant and complemented strains are
shown in Figure 2a. PadA protein was deficient in cell wall extracts
of the ΔpadA and ΔpadA Δhsa mutants, and was highly‐expressed
in the complemented strains following 10 ng nisin ml−1 induction.
Hsa production was detected with succinylated‐wheat germ agglu-
tinin (sWGA), which recognizes the glycosylated protein (Takahashi,
Yajima, Cisar, & Konishi, 2004). Hsa was well‐expressed ectopically
in the complemented Δhsa and ΔpadA Δhsa mutants when induced
with 50 ng nisin ml‐1 (Figure 2b,c). Higher nisin concentrations
were growth‐inhibitory. Production of Hsa from the chromosomal
locus in the ΔpadA mutant was unaffected and was similar to wild
type strain DL1 expression levels (Figure 2c; Petersen et al., 2010).
FIGURE 1 Diagrammatic representation of
PadA protein and N‐terminal F2 domain. (a)
PadA precursor comprises 3,646 aa residues
with N‐terminal region (1,328 aa), and C‐ter-
minal region (2,318 aa) carrying 14 repeat
blocks of 148–152 aa residues and a cell wall
anchor motif LPKTG. The F2 region of the
PadA polypeptide (657 aa) has been
expanded to show the extent of the vWF‐like
domain and the approximate positions of
NGR, RGT, and AGD motifs. (b) aa sequence
of the N‐terminal region 690 aa residues,
indicating signal (leader) sequence (in green),
the vWF‐like domain (purple), and the three
integrin‐recognition motifs, NGR (214–6 aa),
RGT (416–8 aa), and AGD (485–7 aa) in red
type
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2.2 | Role of PadA and Hsa in platelet adhesion by
S. gordonii
It is well documented that Hsa interacts with platelets (Keane et al.,
2010; Kerrigan et al., 2007; Takahashi et al., 2004), and we have previ-
ously shown that PadA also is involved in S. gordonii binding platelets
(Petersen et al., 2010). This is confirmed (Figure 3) with the ΔpadA
mutant being approximately 30% reduced in levels of platelet adher-
ence, and the ΔpadA Δhsa mutant >80% reduced in binding platelets.
Expression of padA in the ΔpadA Δhsa mutant does not restore any
level of platelet adhesion, but expression of hsa restored platelet
binding levels to ~70% of wild type (Figure 3). These results show that
interaction of PadA with resting platelets requires the presence of Hsa.
2.3 | PadA integrin‐recognition motifs are essential
for binding platelets
The above results suggest that Hsa and PadA might participate in a
two‐step reaction with platelets. We envisage that Hsa interacts with
GPIb (Bensing et al., 2004) resulting in inside‐out signalling, activation
of αIIbβ3, and PadA interacting with activated αIIbβ3 (Keane et al.,
2013). In support of this hypothesis, a padA mutant was unaffected
in binding purified αIIbβ3 but was abrogated in binding αIIbβ3 on the
surface of Chinese hamster ovary cells (Petersen et al., 2010). The
purified PadA‐F2 fragment (Figure 1) binds weakly to non‐activated
platelets (Figure 4a) but at high levels to TRAP‐activated platelets
(Figure 4b). We were interested in determining the role of the NGR
motif within PadA‐F2 region because this same motif is present in
fibrinogen and has been shown to interact with αIIbβ3 and activate
platelets (Moriarty et al., 2015). Alanine substitutions of integrin‐like
recognition motifs NGR, RGT, or AGD, to AAA in each case, individu-
ally had no significant effects on binding of F2 fragment to activated
platelets (Figure 4b). However, when all three motifs were substituted,
FIGURE 2 Expression of PadA and Hsa proteins by S. gordonii DL1
wild type, mutants and complemented mutants. (a) (composite), SDS‐
PAGE gel, and corresponding Western immunoblot of PadA
(~350 kDa) in cell wall proteins extracted from: (1) DL1; (2) UB2723
ΔpadA; (3) UB2724 ΔpadA/pMSP‐padA; (4) UB2773 ΔpadA Δhsa; and
(5) UB2775 ΔpadA Δhsa/pMSP‐padA. In lanes 3 and 5, protein
expression was induced with 10 ng nisin ml−1. (b) (composite), whole
cell dot blots reacted with sWGA of: (1) DL1; (2) UB2029 Δhsa; (3)
UB2773 ΔpadA Δhsa; (4) UB2777 ΔpadA Δhsa/pMSP‐hsa; (5)
UB2777 + 10 ng nisin ml−1; and (6) UB2777 + 50 ng nisin ml−1.
(c) Biotinylated sWGA binding to immobilized bacterial cells (2 × 107
per well) followed by HRP‐streptavidin to detect Hsa as described in 4.
Figures in parentheses indicate ng ml−1 nisin added to cultures to
induce expression of Hsa in the complemented strain UB2777 ΔpadA
Δhsa/pMSP‐hsa. Error bars represent ±SEM from two independent
experiments (n = 2). * P < 0.05
FIGURE 3 Platelet adhesion to immobilized S. gordonii strains under
static conditions. Bacterial cells were deposited onto microwells, and
platelet binding was determined by phosphatase assay as described in
4. Figures in parentheses indicate ng ml−1 nisin added to cultures to
induce expression of PadA or Hsa in the complemented strains
UB2775 ΔpadA Δhsa/pMSP‐padA, and UB2777 ΔpadA Δhsa/pMSP‐
hsa. Fibrinogen 100 μg ml−1 positive control; BSA 100 μg ml−1
negative control. Error bars represent ±SEM from four independent
experiments (n = 4). * P < 0.05
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activated platelet binding was abrogated (Figure 4b) while non‐
activated platelet binding was not significantly different from F2
(Figure 4a). Therefore, NGR is not only essential for interaction of PadA
with activated platelets but also requires functional AGD and RGT
motifs (Figure 4b).
Previously, we have suggested that the RGT and AGD motifs
have little or no role in supporting platelet adhesion, but are
involved in the transformation of the platelet biconcave disc
through formation of filopodia and lamellipodia to a fully spread cell
(Keane et al., 2013). Accordingly, we tested the effect of NGRAAA
mutation on platelet spreading and found that for those platelets
that adhered, spreading was unaffected (Figure 5). Taken collec-
tively, these results suggest that NGR plays a major role in
directing adhesion of platelets, while AGD and RGT promote
spreading.
FIGURE 4 Adhesion of non‐activated or TRAP‐activated platelets to
immobilized recombinant PadA‐F2 region fragments under static
conditions. Recombinant PadA protein fragments were immobilized
onto microtitre plate wells (10 μg per well), and non‐specific
binding sites were blocked with BSA. Gel‐filtered platelets were either
non‐activated (a) or activated by addition of TRAP (Thrombin Receptor
Activating Peptide; b) and were incubated with the immobilized pro-
teins at 37°C for 45 min (2 × 107 platelets per well). Platelet adherence
was determined by phosphatase assay. RGTAAA, AGDAAA, NGRAAA,
and so forth indicate the motifs within the various F2 fragments that
were alanine‐substituted to AAA. Error bars represent ±SEM from
three independent experiments (n = 3). * P < 0.05. In (a), NS = not
statistically significant (F2 v F2 RGTAAA AGDAAA, P = 0.429; F2 v F2
NGRAAA RGTAAA AGD AAA, P = 0.962)
FIGURE 5 Platelet spreading on immobilized recombinant PadA‐F2
region fragments under static conditions. (a) BSA (negative control),
(b) fibrinogen (positive control), (c) recombinant PadA protein fragment
F2, or (d) fragment F2 NGRAAA were immobilized onto microtitre plate
wells (10 μg per well), and non‐specific binding sites were blocked with
BSA. Gel‐filtered platelets were incubated with the immobilized sub-
strates at 37°C for 45 min (2 × 107 platelets per well), and platelet
spreading was visualized by confocal microscopy. Scale bar = 15 μm.
(b) Percentage of platelets spread on BSA (negative control), fibrinogen
(positive control), and recombinant PadA protein F2 fragments
immobilized onto glass slides. Error bars represent ±SEM from three
independent experiments (n = 3). NS = not statistically significant
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2.4 | Functions of PadA and Hsa in binding
fibronectin
We then utilized an affinity chromatography proteomics approach to
determine if PadA interacted with specific host proteins present in
human plasma. Purified PadA protein with a ×6 His C‐terminal tag
(PadA6His) was linked to Ni‐NTA magnetic beads and incubated with
plasma. The beads were collected, washed, and the interacting
proteins were eluted, subjected to SDS‐PAGE, in‐gel digested with
trypsin, and analysed by tandem mass spectrometry. Data analysis
(see 4) identified Fn1 protein (fibronectin) (B7ZLE5_HUMAN) as the
highest scoring protein to be pulled down (99% identity confidence/
SEQUEST, 31.16% sequence coverage, 48 unique peptides) relative
to plasma controls. Also, uncharacterized protein Q6GMX0_HUMAN
was identified (47% sequence coverage, 1 unique peptide), recently
annotated as anti‐polyhydroxybutyrate antibody Fv light chain, the sig-
nificance of which is unclear. Fibronectin and Q6GMX0 peptides were
low scoring or non‐detectable, respectively, in parallel plasma controls.
Fibronectin is an extracellular matrix (ECM) protein often found at
sites of endothelial cell damage to which platelets and bacteria are
attracted. Plasma fibronectin (pFn) is a major component of the fibrin
clot (early wound repair), while cellular fibronectin is involved in later
repair events (To & Midwood, 2011). It is known that Hsa is involved
in S. gordonii binding to pFn by recognition of sialylated regions on
the molecule (Jakubovics et al., 2009). Accordingly, we tested the
ΔpadA or Δhsa mutants and complemented strains in adherence to
pFn and to cFn. Levels of binding were slightly higher to cFn, but the
overall adherence patterns of the strains were identical; therefore,
we only present the data for binding to cFn. The ΔpadA mutant was
approximately 25% reduced in binding cFn, while the complemented
strain was above wild type levels of binding (Figure 6). These adher-
ence events were reduced by 50–60% when the cFn was desialylated
(Figure 6). Deletion of hsa led to ablation of cFn binding, while comple-
mentation of the Δhsa mutant led to part‐restoration of cFn‐binding
activity (Figure 6). Complementation of the ΔpadA Δhsa mutant with
padA led to a small increase in cFn binding, while complementation
with hsa restored binding levels to just below wild type (Figure 6).
We therefore conclude that Hsa is a major mediator of Fn binding
under these conditions and that PadA plays a minor, but significant,
role in the process. The fact that adhesion levels are only 50–60%
reduced for desialylated cFn is consistent with the presence of PadA
and other proteins that interact with non‐sialylated Fn (Jakubovics
et al., 2009).
2.5 | Functions of PadA and Hsa in binding
vitronectin
Vitronectin (Vn) is a component of the α‐granules of platelets as well as
being found in ECM where it regulates proteolysis, promotes cell
adhesion and spreading, and modulates the activities of components
of the complement pathway (Singh, Su, & Riesbeck, 2010). Bacteria
coated with Vn evade complement assault, and Vn cross‐links bacteria
and host cells, thence triggering host cell signalling and cytoskeletal
remodelling (Singh et al., 2010). Accordingly, we also determined the
role of PadA and Hsa in binding to Vn. Deletion of padA resulted in
60% reduction in Vn‐binding levels (Figure 7) while adherence was
fully restored by complementation with padA (Figure 7). Deletion of
hsa abrogated binding of mutant cells to Vn, and complementation
with ectopic hsa restored binding to about 45% of wild type levels.
Interestingly, complementation of ΔpadA Δhsa with either padA or
hsa alone did not complement the Vn‐binding phenotype. These
results strongly indicate that Hsa requires the presence of functional
PadA in order to efficiently bind Vn. Lastly, adherence of streptococcal
cells to Vn was ablated by sialidase (neuraminidase) treatment of Vn,
implying that Vn adherence is sialylation dependent (Figure 7).
2.6 | Functions of PadA and Hsa in adherence to
salivary glycoproteins and in biofilm formation
S. gordonii is normally found in the oral cavity and produces a spectrum
of adhesins that interact with salivary components (Nobbs, Lamont, &
Jenkinson, 2009). To test the effects of padA or hsa deletions on initial
streptococcal adherence to salivary pellicle, bacteria were incubated
with saliva‐coated glass cover slips, and levels of adhesion determined
by crystal violet staining. We detected significant differences in
adherence of the ΔpadA and ΔpadA Δhsa mutants compared with wild
type DL1 (Figure 8). Complementation with padA restored adherence
levels while complementation with hsa did not (Figure 8).
FIGURE 6 Adhesion of S. gordonii strains to human cellular fibronectin
(cFn). Microtitre plate wells were coated with cFn (1 μg per well),
blocked with BSA, and then incubated with streptococcal cells (5 × 107
per well) for 2 hr at 37°C. Bacterial cells adhered (black columns) were
quantified by staining with crystal violet as described in 4. Wells
coated with cFn were also incubated with 0.001 U neuraminidase
(sialidase) for 2 hr at 37°C, washed, blocked with BSA and then
incubated with streptococcal cells (grey shaded columns). Expression
of PadA or Hsa proteins by complemented strains was induced with
10 ng or 50 ng nisin ml−1. Error bars represent ±SEM from three
independent experiments (n = 3). * P < 0.05 for comparisons indicated;
§ P < 0.05 for neuraminidase‐treated cFn versus untreated
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In subsequent biofilm formation, the ΔpadA mutant was 50%
decreased in biomass compared to wild type, and complementation
with padA restored biomass to slightly above wild type levels
(Figure 8). Deletion of hsa resulted in similar effects, and complemen-
tation of the Δhsa mutant was highly effective in enhancing biofilm
formation. The ΔpadA Δhsa mutant was ablated in biofilm formation
(Figure 8). Complementation with padA restored biofilm formation,
but complementation with hsa did not (Figure 8). These results suggest
that PadA must be fully functional for Hsa to promote biofilm forma-
tion. However, it also appears that PadA alone can provide the neces-
sary function for biofilm formation in the absence of Hsa (Figure 8).
2.7 | PadA integrin‐recognition motifs are not
involved in binding cFn, Vn, or salivary pellicle
Because the previous data strongly suggest that PadA is involved in
binding ECM substrata and salivary pellicle, we tested the ability of
the PadA‐F2 region to mediate these interactions, and the role of the
three integrin‐recognition motifs. In binding assays of purified F2
fragments to immobilized substrata, it was found that levels of binding
to cFn were higher than to Vn and pellicle (Figure 9). Substitution of all
three integrin‐recognition motifs (RGT, AGD, and NGR) with AAA
failed to significantly affect levels of adhesion of the PadA‐F2 fragment
to Fn, but there was slightly elevated interaction with Vn and with
salivary pellicle (Figure 9). Sialidase treatment of the substrata did not
affect levels of PadA‐F2 binding compared to untreated substrata
(Figure 9).
FIGURE 7 Adhesion of S. gordonii strains to human vitronectin (Vn).
Microtitre plate wells were coated with Vn (0.05 μg per well),
blocked with BSA, and then incubated with streptococcal cells (5 × 107
per well) for 2 hr at 37°C. Bacterial cells adhered (black columns) were
quantified by staining with crystal violet as described in 4. Wells
coated with Vn were also incubated with 0.001 U neuraminidase
(sialidase) for 2 hr at 37°C, washed, blocked with BSA, and then
incubated with streptococcal cells (grey columns). Expression of PadA
or Hsa proteins by complemented strains was induced with 10 ng or
50 ng nisin ml−1, respectively. Error bars represent ±SEM from three
independent experiments (n = 3). * P < 0.05 for comparisons indicated;
§ P < 0.05 for neuraminidase‐treated Vn versus untreated
FIGURE 8 S. gordonii strains adherence to salivary pellicle and biofilm
formation. Cover slips were coated with salivary pellicle and incubated
with streptococcal cells (5 × 107 per well) for 2 hr at 37°C for
adherence (grey columns) or in YPT‐Glc medium for 16 hr at 37°C for
biofilm formation (black columns). Bacterial cells adhered, and biofilm
biomass values were quantified by staining with crystal violet as
described in 4. Expression of PadA or Hsa proteins by complemented
strains was induced with 10 ng or 50 ng nisin ml−1, respectively. Error
bars represent ±SEM from three independent experiments (n = 3).
* P < 0.05 for biofilm comparisons indicated; § P < 0.05 for significantly
different adherence versus DL1
FIGURE 9 Adhesion of PadA‐F2 region fragments to cellular
fibronectin (cFn), vitronectin (Vn), or salivary pellicle (SP). cFn, Vn, or
saliva were immobilized onto microtitre plate wells and non‐specific
binding sites were blocked with BSA (black columns). Wells coated with
cFn, Vn, or salivary glycoproteins were also incubated with 0.001 U
neuraminidase (sialidase) for 2 hr at 37°C, washed, and blocked with
BSA (grey columns). Recombinant proteins (100 μg ml−1) were
incubatedwith substrata for 2 hr at 37°C and amounts boundmeasured
with anti‐tetra‐His mouse antibodies and HRP‐conjugated anti‐mouse
IgG antibodies as described in 4. F2, unmodified fragment; F2*,
fragment containing NGR, RGT, and AGDmotifs all alanine‐substituted
to AAA. Error bars represent ±SEM from three independent
experiments (n = 3). * P < 0.05 compared with corresponding F2 values
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3 | DISCUSSION
S. gordonii is a component of the normal microbiota of the human oral
cavity and plays a pivotal role in the development of microbial
communities on the tooth surfaces and gingival crevices (Jenkinson,
2011; Wright et al., 2013). These communities provide a reservoir for
bacteria to enter the circulation where they may interact with blood
platelets and cause unwanted thrombus generation. This can lead to
infective endocarditis, which is characterized by the formation of
vegetations on the heart valves (Moreillon & Que, 2004). Significant
advances in our understanding of how S. gordonii, and other mitis‐
group oral bacteria, interact with platelets have been made in
recent years.
In addition to the knowledge about S. gordonii Hsa and GspB pro-
teins (Takahashi et al., 2002; Xiong, Bensing, Bayer, Chambers, &
Sullam, 2008), and how they are able to interact with platelet integrin
GPIb (Takamatsu et al., 2005), we have demonstrated that PadA
surface protein can bind to platelets in a αIIbβ3‐dependent manner
(Petersen et al., 2010) causing dense granule secretion and full platelet
spreading (Keane et al., 2010). The N‐terminal region of 1328 aa resi-
dues interacts with platelets (Keane et al., 2013; Petersen et al., 2010),
and here, we show that the same region binds Vn, Fn, and salivary
pellicle. The PadA C‐terminal region comprising 2,318 aa residues
has no defined function at this stage. It is thought that this region
containing aa residue repeat blocks (Figure 1) may act as a flexible stalk
holding the N‐terminal binding‐region of the protein out into the
environment. C‐terminal region repeat‐block regions of other S. gordonii
surface proteins, such as CshA and Hsa, are reported to provide
extended conformations (McNab et al., 1999; Takahashi et al., 2002)
that may assist in capture of their ligands even under conditions of
shear or flow (Kerrigan et al., 2007).
In the first part of the present study, we focused on the roles of
three integrin‐like recognition motifs within the N‐terminal PadA‐F2
fragment (657 aa residues) in the interactions of PadA with platelets.
We showed previously that neither RGT(416–418) nor AGD(485–487)
were necessary for supporting static or shear‐induced platelet
adhesion, but both motifs contributed to platelet spreading (Keane
et al., 2013). This is in keeping with the data suggesting that Hsa is
essential for platelet capture under shear and thus responsible for
platelet rolling (Bensing et al., 2004; Kerrigan et al., 2007). Firm
adhesion is then complete when platelet integrin αIIbβ3 interacts with
PadA (Petersen et al., 2010). Recent evidence indicates that another
motif, NGR, within fibrinogen is responsible for interaction with αIIbβ3
and triggering platelet activation (Moriarty et al., 2015). In light of this
discovery, we investigated the role of an identical motif NGR(214–216)
within the N‐terminal region of PadA to direct interactions with
platelets. In our experiments with platelets that were specifically in
resting state, we found that the PadA‐F2 fragment bound these only
weakly (Figure 4a). However, the immobilized PadA‐F2 region bound
TRAP‐activated platelets, so this would be in keeping with the notion
that PadA preferentially interacts with αIIbβ3 that is in an activated
complex with GPIb following Hsa‐binding. Confirming our previous
studies, we showed that RGT and AGD were not essential for PadA‐
F2 binding to TRAP‐activated platelets. However, binding of the
PadA‐F2 fragment to activated platelets required the combined
activities of NGR, RGT, and AGD, because alanine‐substitutions of all
of these motifs ablated adhesion (Figure 4b). Moreover, we could not
demonstrate that the NGR motif alone was necessary for full platelet
spreading, while RGT and AGD motifs clearly contribute to the full
spreading process (Keane et al., 2013). In summary, we are nearing
the situation in which we could potentially target these three motifs
within PadA as a means to controlling unwanted platelet activation
by circulating S. gordonii, and by other oral streptococci that express
PadA‐like proteins.
In this study, we have also utilized gene knockouts and respective
complemented strains of S. gordonii in order to dissect the relative
functions of PadA and Hsa in host tissue interactions. Our results have
uncovered some unexpected dependencies of the two proteins on
each other for their adhesive functions. Platelet adhesion depends
upon the dual functioning of Hsa and PadA, as previously interpreted,
but knock‐in of PadA to a ΔpadA Δhsa double mutant does not restore
adhesion, only knock‐in of Hsa part‐restores adhesion. This appears to
support evidence that PadA contributes to adhesion only when
platelets have first been engaged with Hsa. The fact that knock‐in of
Hsa does not fully restore platelet adhesion shows the requirement
of PadA for complete engagement (Figure 3).
Our experiments with S. gordonii mutants also demonstrate that
PadA and Hsa are involved in binding Fn and Vn. Binding of S. gordonii
to cFn is in part sensitive to sialidase treatment of cFn, and this is
consistent with the known activity of Hsa in Fn‐binding by S. gordonii
(Jakubovics et al., 2009). It is possible that regions outside the Siglec‐
like sialic acid‐binding domain within the BR (binding region) of Hsa
(Pyburn et al., 2011) interact with Fn. For example, the BRs of Strepto-
coccus agalactiae serine‐rich repeat proteins Srr1 and Srr2 have been
shown to bind fibrinogen (Seo et al., 2013). Another S. gordonii surface
protein that interacts with Fn is CshA (McNab et al., 1999). Neither
CshA nor PadA contain primary sequences or motifs that have been
associated with Fn recognition by other Gram‐positive bacterial cell
surface proteins (Henderson, Nair, Pallas, &Williams, 2011). The mech-
anism of cFn binding by PadA is currently under investigation. In sum-
mary, Hsa is a major component of the S. gordonii cell surface that
binds sialylated Fn. PadA also binds cFn, but this is less effective in
the absence of Hsa (Figure 6) suggesting that, like for platelets, Hsa
binding sialic acid residues promotes PadA function.
The finding that ΔpadA and Δhsa mutants of S. gordonii are also
deficient in binding to Vn may have significance in the overall pro-
cesses of platelet binding and activation, and in immune evasion. Vn
is present in plasma, ECM and in platelet α‐granules. Blood platelets
secrete multimeric Vn following activation, although about 50%
remains platelet bound (Parker, Stone, White, & Seinshaw, 1989). Vn
forms complexes with plasminogen activator inhibitor‐1 (PAI‐1) and
thus behaves as a physiological inhibitor of active thrombin. Con-
versely, Vn also appears to stabilize the thrombus and, so, plays a dual
role in mediating platelet adhesion (Thiagarajan & Kelly, 1988) and
aggregation (Reheman et al., 2005). Vn carries binding sites for heparin,
PAI‐1, integrins, collagen and plasminogen (Ekmekçi & Ekmekçi, 2006)
and also binds αIIbβ3. Thus, S. gordonii might be able to interact with
platelets via Vn, which may be bound to β3 integrins or to surface‐
associated collagen. Furthermore, bacteria coated with Vn are able to
evade the membrane attack complex (MAC) by blocking complement
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components (C5b‐7 complex and C9) and conferring serum resistance
(Singh et al., 2010). This of course would be a crucially important prop-
erty for augmenting systemic survival of bacteria. Our data suggest
that binding of streptococcal cells to Vn is dependent on glycan moie-
ties, in particular sialic acid, because sialidase treatment of Vn led to
ablation of streptococcal cell adhesion. The major N‐linked oligosac-
charides of Vn consist of the N‐acetyllactosamine type, with a major
proportion of them sialylated (Ogawa et al., 1995). Our adherence data
for knock‐out and complemented mutants strongly suggest that both
PadA and Hsa are involved in Vn recognition, since complementation
of ΔpadA Δhsa double knock‐out mutants with either PadA or Hsa
was not sufficient to restore Vn binding. This again provides evidence
for concerted activities of PadA and Hsa. Overall, PadA would seem
therefore to be a versatile molecule with a range of properties that
would enable it to modulate thrombogenesis, accelerate the
thrombotic response, facilitate the incorporation of bacterial cells into
vegetations and into hemostatic plaques (Brown, Lundgren, Nordt, &
Fujii, 1994) and help S. gordonii resist complement‐mediated lysis by
binding Vn.
Experiments investigating adherence to salivary pellicle and bio-
film formation set out to determine if there were roles for the PadA
and Hsa proteins in oral cavity colonization outside of pathogenesis
within the circulatory system. It is already known that Hsa and GspB
bind salivary proteins (Takamatsu, Bensing, Prakobphol, Fisher, &
Sullam, 2006), and that Hsa is required for intergeneric coaggregation
with Veillonella species (Zhou, Liu, Li, Takahaski, & Qi, 2015). However,
this is not sialic acid‐dependent, providing further evidence for the
presence of additional binding sites within the BR of Hsa. The ability
of S. gordonii to adhere to pellicle is antecedent to biofilm formation.
Both PadA and Hsa appear to contribute to biofilm formation and
complementation of ΔpadA or Δhsa single knock‐out mutants restores
the ability to form biofilms in each case. However, only complementa-
tion of the ΔpadA Δhsa mutant with PadA restored biofilm formation,
not complementation with Hsa. We conclude with an important inter-
pretation that the role of Hsa in biofilm formation is only effective in
the presence of PadA. Clearly, therefore, PadA has the ability to medi-
ate S. gordonii binding to salivary pellicle in the absence of sialic acid
receptors (Figure 9), and to promote cell–cell interactions that also
do not involve sialic acid receptors and result in biofilm formation. This
could mean that biofilm formation is a two‐step process, and that PadA
provides the first step (as opposed to the secondary step in binding
platelets). Alternatively, Hsa and PadA may independently contribute
to biofilm formation but Hsa is not functionally expressed without
the presence of PadA. This might suggest that a complex is formed
between PadA and Hsa on the S. gordonii cell surface, and this possibil-
ity is currently under investigation.
In conclusion, PadA is a multi‐domain adhesin that interacts with
activated platelets via αIIbβ3 facilitating firm adhesion, granule release,
and full platelet spreading (see Figure 10). These properties depend
upon the presence of NGR, RGT, and AGD integrin‐like recognition
motifs within the N‐terminal F2 fragment of 657 aa residues. These
motifs are not involved in PadA‐F2 fragment binding to cFn, Vn, or
salivary pellicle, suggesting that they are more critical to platelet
interactions, and that the alanine substitutions did not significantly
affect the general adhesion properties of the F2 region. PadA functions
in concert with Hsa, mediating firm adhesion of platelets following
FIGURE 10 Diagrammatic representation of
some of the processes involved in platelet
activation by S. gordonii. Cell wall‐anchored
proteins Hsa and PadA interact with platelet
membrane integrins GPIb and αIIbβ3
(GPIIbIIIa). Hsa captures platelets under flow
(rolling) by binding GPIb, and possibly also
αIIbβ3, and activates signalling cascades
including FcγRIIa phosphorylation, leading to
dense granule release (see Arman et al., 2014).
PadA binds activated αIIbβ3, thus amplifying
signals leading to shape change, thrombin
production, coagulation, and thrombus
formation. Platelet activation by S. gordonii can
occur in the absence of specific IgG. However,
with IgG present, there is evidence for
activation (phosphorylation) of spleen tyrosine
kinase (Syk‐P) through FcγRIIa. Conserved
streptococcal surface protein antigens such as
antigen I/II proteins (e.g., SspA/B) may also be
involved in the overall process (Kerrigan et al.,
2007). Physiologically, collagen activates Syk
through GPVI, which is closely associated with
FcγRIIa (not shown). Fibrinogen engages
GPIIbIIIa (αIIbβ3), which also associates with
FcγRIIa. CD40L (otherwise known as CD154)
is up‐regulated in the platelet cell membrane
and binds CD40+ cells such as endothelial cells
and neutrophils, while soluble (released)
CD40L further activates platelets
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capture of platelets by Hsa via GPIb, and firm adhesion to cFn. PadA
and Hsa also act cooperatively in mediating binding of bacteria to Vn,
salivary pellicle, and biofilm formation. In the latter phenotype, Hsa is
clearly reliant on PadA expression to mediate its function. Taken
collectively, these results strongly suggest that in S. gordonii at least
two cell wall‐anchored proteins work in concert to mediate host‐
interactive processes relevant to both bacterial colonization and
pathogenesis.
4 | EXPERIMENTAL PROCEDURES
4.1 | Bacterial growth conditions
Streptococcus gordonii DL1‐Challis, isogenic mutants UB2723 ΔpadA::
aad9, UB2029 Δhsa::aphA3, UB2773 ΔpadA::aad9 Δhsa::aphA3, and
mutant strains complemented with pMSP‐padA or pMSP‐hsa, were
routinely grown on BHY agar (37 g l−1 Brain Heart Infusion, 5 g l−1
Yeast Extract, 15 g l−1 agar) or in BHY broth, at 37°C under CO2‐
enriched conditions (candle jar). Less complex TY medium (5 g l−1
Bacto‐tryptone, 4 g l−1 yeast extract, 4 g l−1 K2HPO4, adjusted to
pH 7.5 with HCl) containing 0.5% glucose (TY‐Glc) was employed for
protein purification from S. gordonii UB2870 ΔpadA/pMSP‐padA6His.
Protein expression from pMSP was under control of a nisin‐inducible
(10–50 ng ml−1) promoter (Bryan, Bae, Kleerebezem, & Dunny, 2000;
Hirt, Erlandsen, & Dunny, 2000). Escherichia coli strains DH5α,
JM109, XL1‐Blue, Stellar® and BL21 for plasmid preparation and pro-
teinexpressionweregrownonLBagaror in LBbrothat37°C.Antibiotics
were incorporatedwherenecessaryforstreptococci [5 μg erythromycin
(Em) ml−1; 100 μg spectinomycin (Sp) ml−1; 250 μg kanamycin (Kn) ml
−1] or E. coli [100 μg ampicillin (Ap) ml−1; 250 μg Em ml−1].
4.2 | Generation of S. gordonii gene knockout strains
Plasmids or PCR amplimers were purified using QIAquick Spin
Miniprep or PCR Purification kits respectively (Qiagen, Manchester,
UK). Oligonucleotides (Table 1) were synthesised by MWG Eurofins
(Wolverhampton, UK). Chromosomal DNA was extracted from
mutanolysin‐treated S. gordonii DL1 cells, as described previously
(Jenkinson, 1987). DNA restriction and modification enzymes were
used under the conditions specified by the manufacturer (New
England Biolabs, Hitchin, Herts, UK).
The padA gene of S. gordonii DL1 was deleted by allelic exchange
with the Sp resistance determinant aad9. PCR amplification using
Expand Long PCR System (Roche, Burgess Hill, West Sussex, UK) with
primers padA.F1/padA.R1 and padA.F2/padA.R2 and S. gordonii DL1
chromosomal DNA template generated two fragments comprising
the flanking sequences of the padA gene (676 BP, 518 BP) with a unique
NarI site at their 3′ and 5′ ends, respectively. These were stitched
together in a second round of PCR using primers padA.F1/padA.R2
generating a 1155‐bp amplimer with an internal unique NarI site. The
fragment was subsequently cloned into pGEM‐T Easy to generate
construct pGEM‐padAflank and transformed into chemically‐induced
competent cells (Hanahan, 1983) of Escherichia coli XL1‐Blue. The
aad9 gene was PCR amplified from plasmid pFW5 (Podbielski,
Spellerberg, Woischnik, Pohl, & Lútticken, 1996) using primers aad9F.
NarI/aad9R.NarI and then sub‐cloned into the NarI site of pGEM‐
padAflank to generate construct pGEM‐padAflank::aad9. PCR amplifi-
cation from pGEM‐padAflank::aad9 with primers padA.F1/padA.R2
generated amplimer padAflank::aad9, which was transformed into
S. gordonii DL1 as described by Haisman and Jenkinson (1991) to
produce the padA gene knockout mutant (designated UB2723). Confir-
mation of successful mutagenesis was obtained by sequencing the
PCR product amplified from the chromosomal locus with primer pair
padA.F1/padA.R2. Absence of PadA protein from the cell wall of the
mutant was verified by Western immunoblotting using anti‐PadA anti-
bodies (Petersen et al., 2010).
To generate a S. gordonii DL1 ΔpadA Δhsa double‐knockout
mutant, S. gordonii UB2029 Δhsa::aphA3, a reisolate of UB1545
(Jakubovics et al., 2005), was used as recipient for allelic replacement
TABLE 1 List of primers. Restriction enzyme sites are underlined
Primer Sequence
aad9.seqF 5′ GGATACATTCCTCAGAAGGAA 3’
padA.F1 5′ GGCCTCGAGCGGAATTTAACTAGGAGGG 3’
padA.R1 5′ CCTGGACGGCGCCCATGCTATTTTAAAGCCTATATAA 3’
padA.F2 5′ TAGCATGGGCGCCGTCCAGGAGAGCTATGCTCTT 3’
padA.R2 5′ TCCCCCCGGGGTCGTAATCTCTGGTTGAGG 3’
aad9F.NarI 5′ CGCGGCGCCCGTAACGTGACTGGCAAG 3’
aad9R.NarI 5′ CGCGGCGCCGATGCATATGCATGCTGC 3’
Terminator.XhoF 5′ ATGATACATGCTCGAGGAATTAGGTTGAAAAAATAGAAGG3’
Terminator.XhoR 5′ GGAGACCGGCCTCGACTGAACACAAAGCTCGTAAGATC 3’
padA.pMSPF 5′ ATGATACATGCTCGAGGATTTTTTGAAAAAGGTTTTAATAC 3’
padA.pMSPR 5′ AACCTAATTCCTCGAGTTAATGCTTTGGTTTTCTTCTC 3’
JH5F 5′PHO‐ GCTGCTGCAATCACACAGACCGGTAACAAGG 3′
JH6R 5′PHO‐GATTTCCTTGCTAGGGTCTGTTACTTTCGG 3′
JH19F 5′PHO‐ GCGGCCGCTAAGACGGTCTTCCTCCTAGTAACGG 3’
JH20R 5′ PHO – TTCCATATTCCCTTTGACACGGTTGTACTGAGC 3’
His.padAR 5′ ATGATGATGTGCTCCGTCTTTAATAGATG
His.padAF 5′ CACCACCACTAACTCGAGGAATTAGGTTG
HAWORTH ET AL. 9
of the padA gene with aad9. Primers padA.F1/padA.R2 were utilized to
amplify with PrimeSTAR Max polymerase (Takara Biotechnology,
Shiga, Japan) a 2‐kb fragment from UB2723 chromosomal DNA. The
amplimer was purified and transformed into S. gordonii UB2029 with
selection for KnR and SpR, and colonies were screened by PCR using
primers aad9.seqF/padA.R2 to detect the aad9 cassette. Several
transformants were checked by sequencing PCR products generated
from across the loci and a representative transformant was purifed
and designated UB2773.
4.3 | Generation of S. gordonii complemented mutant
strains
To complement the S. gordonii UB2723 ΔpadAmutant, the entire padA
coding sequence was cloned into pMSP, a derivative of pMSP7517
(Hirt et al., 2000) in which the prgB gene had been replaced by DNA
encoding three alanine residues, together with the transcriptional ter-
minator of the padA operon. In brief, a 227‐bp region downstream of
SGO_RS09805 incorporating the padA operon transcriptional termina-
tor was amplified from S. gordonii DL1 chromosomal DNA using
PrimeSTAR® GXL polymerase (Takara Biotechnology, Shiga, Japan)
with primers Terminator.XhoF/Terminator.XhoR. The amplimer was
cloned using In‐Fusion HD Cloning Kit (Clontech, Oxford, UK) into
vector pMSP, which had been linearized by digestion with XhoI. The
primers were designed such that only the XhoI site at the 5′ end of
the transcriptional terminator would be retained upon cloning. This
construct (pMSP‐term) was transformed into E. coli K12 and confirmed
by sequencing. The padA gene (10,967 BP) was then amplified using
primers padA.pMSPF/padA.pMSPR and cloned via XhoI sites at its ter-
mini into pMSP‐term that had been similarly digested. The resulting
construct (pMSP‐padA) was transformed into E. coli K12 and confirmed
by sequencing. The construct was then transformed into S. gordonii
UB2723 ΔpadA and into UB2773 ΔpadA Δhsa to generate
complemented mutants. PadA expression was under control of the
nisin‐inducible promoter present in pMSP, and so following nisin‐
induction (10–50 ng ml−1) PadA expression by the complemented
strains was confirmed by Western immunoblot of cell wall protein
extracts and whole cell FACS analyses, with anti‐PadA antibodies
(Figure 2).
To purify PadA from S. gordonii, plasmid pMSP‐padA was
used as template in inverse PCR with 5′ phosphorylated primers
His.padAR 5′ATGATGATGTGCTCCGTCTTTAATAGATG and His.
padAF CACCACCACTAACTCGAGGAATTAGGTTG to substitute the
sequence encoding the PadA wall anchorage motif (LPKTG) with a
sequence encoding ×6 His (underlined in primers), followed by a stop
codon. Amplicons were ligated following removal of original template
by DpnI digestion, and resulting plasmids were transformed into E. coli
JM109. Several plasmids were confirmed by sequencing, and then
transformed into S. gordonii UB2723 ΔpadA. A representative strain
was selected in which padA gene expression was induced with nisin
(50 ng ml−1), and PadA protein, in the absence of cell wall anchorage
motif, was secreted into the growth medium (Figure S1).
Generation of plasmid pMSP‐hsa carrying the complete coding
sequence of hsa and S. gordonii strain Δhsa/pMSP‐hsa (UB1746) have
been described previously (Jakubovics et al., 2009). To make a
complement in S. gordonii UB2773 Δhsa ΔpadA double mutant,
pMSP‐hsa was transformed into this strain to generate S. gordonii
UB2777 Δhsa ΔpadA/pMSP‐hsa. The S. gordonii pMSP‐hsa
complemented strains were induced with nisin (10–50 ng ml−1) and
subjected to lectin immunoblotting with sWGA to confirm Hsa expres-
sion (Jakubovics et al., 2009; Figure 2).
4.4 | Site‐directed mutagenesis and protein
expression
Site‐directed mutagenesis of two potential integrin‐recognition sites in
the F2 N‐terminal region of PadA have been previously described
(Keane et al., 2013). Briefly, alanine‐substitution mutagenesis was
performed by the use of mutagenic primers containing base mis-
matches in inverse PCR amplification of pET46‐F2, containing the
PadA‐F2 domain coding sequence to generate pET46‐F2 NGRAAA,
pET46‐F2 RGTAAA or pET46‐F2 AGDAAA. In addition to the base
mismatches corresponding to the alanine substitutions, a new
engineered restriction site was introduced into each plasmid, enabling
restriction digest to generate compatible ends for self‐ligation to
reform a circular plasmid.
A modified alanine substitution method was employed to generate
double and triple motif substitutions. In summary, this technique
avoided the need for restriction digests to prepare complementary
ends and instead made use of 5′ phosphate groups on the primers to
enable plasmid self‐ligation. pET46‐F2 AGDAAA was extracted and
purified from E. coli JM109 and used as template DNA for inverse
PCR amplification using primers JH5F/JH6R. These primers incorpo-
rated 5′phosphate groups and base mismatches to generate both the
alanine substitutions and an engineered AgeI site to facilitate screening
by restriction digest analysis. Phusion DNA Polymerase (Life Technol-
ogies, Paisley, UK) was used in a two‐step protocol to generate the
desired amplimer of 7200 BP. This was treated with DpnI for 1 hr at
37°C to remove template DNA and subsequently purified. The purified
DNA was self‐ligated using T4 DNA ligase for 16 hr at 16°C and
subsequently transformed into competent E. coli JM109 cells.
Transformants were selected for ApR, and colonies were screened for
plasmids that were cut with AgeI, indicating the formation of pET46‐
F2 RGTAAAAGDAAA, and this was confirmed by sequencing. Purified
plasmid was then transformed into competent E. coli BL21 cells for
recombinant protein production (see below).
Generation of a pET46‐F2 NGRAAARGTAAAAGDAAA plasmid
construct was achieved using a similar alanine substitution technique
to that used to generate the pET46‐F2 RGTAAAAGDAAA construct.
Briefly, the template plasmid pET46‐F2 RGTAAAAGDAAA was extracted
and purified from E. coli JM109. 5′‐phosphate‐modified JH19F and
JH20R primers, which incorporated an engineered NotI restriction site,
were used in Phusion PCR to generate the desired amplimer (7200 BP),
which was subsequently treated with DpnI, self‐ligated and
transformed into competent E. coli JM109 cells. Plasmids from
transformant cells were extracted, purified, and analysed by NotI
restriction digest. Plasmids that gave the correct NotI restriction digest
pattern were likely to be the desired constructs. This was confirmed by
sequencing, before transformation of individual plasmids into compe-
tent E. coli BL21 cells.
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4.5 | Protein expression and purification
Recombinant protein expression was induced in E. coli BL21 cultures at
OD600 0.5–0.7 by adding IPTG at a final concentration of 1 mM, and
continuing incubation for 4 hr at 37°C with shaking at 220 rpm. Cells
were harvested by centrifugation (5000 × g, 10 min), and the pellet
was lysed in 2 ml Buffer B (8 M urea, 0.1 M NaH2PO4, 0.01 M Tris–
HCl, pH 7.0) supplemented with 0.1 M phenylmethanesulfonylfluoride
(PMSF) at room temperature for 4 hr. Cell debris was removed by cen-
trifugation (12,000 × g, 15 min). Ni‐NTA agarose (Qiagen; 300 μl) was
added to 2 ml lysis supernatant, mixed gently at room temperature for
25 min, and then transferred to a polypropylene column (Qiagen). The
column was washed with 4 ml Buffer B (supplemented with 20 mM
imidazole) and then twice with Buffer C (1 M NaCl, 10% EtOH, 2%
Tween‐20) supplemented with 20 mM imidazole. Protein was eluted
six times with Buffer D (Buffer B, supplemented with 100 mM imidaz-
ole). All of the washes and eluted fractions were collected and analysed
by SDS‐PAGE. Fractions containing recombinant proteins were pooled
and dialysed against dH2O supplemented with protease inhibitor cock-
tail (Sigma). Dialysed protein solutions were freeze‐dried, suspended in
dH2O, and the protein concentrations determined using the Bradford
assay (BioRad Laboratories, Hemel Hempstead, Herts, UK).
4.6 | PadA6His expression and purification from S.
gordonii
S. gordonii UB2870 ΔpadA/pMSP‐padA6His cultures were grown in TY‐
Glcmediumat37°CwithSp,Emand100ngml−1nisin, to early stationary
phase. The cultures were centrifuged (12,000 × g, 4°C, 20 min), the
supernatants were collected, protease inhibitor cocktail (Sigma) added,
and then passed through a 0.45 μm filter. The fluid was concentrated
to 4 ml, using a centrifugal filter unit, and centrifuged (12,000 × g, 4°C,
10 min) to remove particulate matter. The fluid was then dialysed into
Buffer A (50 mM Tris, 200 mM NaCl, 10% glycerol, 0.1% Triton X‐100,
pH 7.5) for 16 hr at 4°C. A HiTrap Ni2+ affinity column (GE Healthcare,
Cardiff, UK) was pre‐equilibrated in Buffer A, the protein sample was
loaded onto the column, and non‐specifically bound proteins were
removed by washing the column first with Buffer A (5 ml) and then with
Buffer B (50 mM Tris, 200 mM NaCl, 10% glycerol, 0.1% Triton X‐100,
20 mM imidazole, pH 7.5). The PadA6His protein was eluted with 15 ml
Buffer C (50 mM Tris, 200 mM NaCl, 10% glycerol, 0.1% Triton X‐100,
500 mM imidazole, pH 7.5) and collected in 3 ml fractions. These were
analysed by SDS‐PAGE and fractions containing pure PadA6His were
pooled and dialysed into Buffer A for 16 hr at 4°C. Identity and
purity were confirmed by liquid chromatography‐mass spectrometry
(LC–MS) analysis (University of Bristol Proteomics Facility).
4.7 | Pull‐down assay
Dynabeads® His‐Tag Isolation and Pulldown kit (Life Technologies)
was used for PadA‐serum pull‐down assays according to the manufac-
turer's recommended instructions. PadA6His (4 mg ml
−1) was diluted in
Binding/Wash buffer and incubated with mixed pooled human plasma
(TCS Biosciences, Botolph Claydon, Bucks, UK) diluted 1:5 in Pull‐
down buffer. Elution steps were performed according to the manufac-
turer's instructions.
4.8 | Mass spectrometry sample preparation
To prepare the eluted samples from the pull‐down assays for MS, the
samples were subjected to SDS‐PAGE until the dye‐front had moved
1.5 cm into the gel. The gel was stained with Coomassie blue,
destained, and a single gel slice encompassing proteins below
350 kDa was excised. The slice was subjected to in‐gel tryptic diges-
tion with a ProGest automated digestion unit (Digilab UK). The
resulting peptides were fractionated with a Dionex Ultimate 3000
nanoHPLC system in line with an LTQ‐Orbitrap Velos mass spectrom-
eter (Thermo Scientific) controlled by Xcalibur 2.1 software (Thermo
Scientific). The Orbitrap was set to analyse the survey scans at
60,000 resolution (at m/z 400) in the mass range m/z 300 to 2,000
and the top twenty multiply‐charged ions in each duty cycle were
selected for MS/MS in the LTQ linear ion trap.
4.9 | Liquid chromatography‐mass spectrometry
data analysis
The raw data files were processed and quantified using Proteome Dis-
coverer software v1.2 (Thermo Scientific) and searched against the
UniProt/SwissProt S. gordonii (strain Challis/ATCC 35105/CH1/DL1/
V288) database (2,056 entries) and the UniProt/SwissProt Homo
sapiens database (70,625 entries) using SEQUEST (Ver. 28 Rev. 13)
algorithm for the pull‐down elution samples. Peptide precursor mass
tolerance was set at 10 ppm, and MS/MS tolerance was set at
0.8 Da. Search criteria included carbamidomethylation of cysteine
(+57.0214) as a fixed modification and oxidation of methionine
(+15.9949) as a variable modification. Searches were performed with
full tryptic digestion, and a maximum of one missed cleavage was
allowed. The reverse database search option was enabled, and all
peptide data were filtered to satisfy false discovery rate (FDR) of 5%.
The Proteome Discoverer software generates a reverse “decoy”
database from the same protein database, and any peptides passing
the initial filtering parameters that were derived from this decoy data-
base are defined as false positive identifications. The minimum cross‐
correlation factor (Xcorr) filter was readjusted for each individual
charge state separately to optimally meet the predetermined target
FDR of 5% based on the number of random false positive matches
from the reverse decoy database. Thus, each data set has its own
passing parameters.
4.10 | Platelet adherence assay
Whole blood was collected from six donors and added to 1.5 ml acid
citrate dextrose per 10 ml blood collected. The donors were healthy
subjects who had abstained from taking any non‐steroidal anti‐
inflammatory drugs (NSAIDs) in the previous 10 days. Informed con-
sent was obtained from all subjects, and the study was approved by
the Royal College of Surgeons in Ireland Ethics Committee (REC679b).
Blood was centrifuged (150 × g, 10 min), and the upper platelet‐
containing fraction was carefully removed to a fresh tube. The
platelet‐rich plasma (PRP; collected in acid‐citrate dextrose, ACD) was
adjusted to pH 6.5 with ACD. Apyrase (1 U ml−1), and prostaglandin‐
E1 (Sigma Aldrich; 2 μM) were added to the PRP, and the sample was
centrifuged (650 × g, 10 min, 20°C). The upper layer containing
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platelet‐poor plasma was removed, and the platelet pellet was
suspended in 2ml modifiedHEPES‐Tyrode buffer (JNL; 6mMdextrose,
130 mM NaCl, 9 mM NaHCO3, 10 mM Na citrate, 10 mM Tris base,
3 mM KCl, 0.8 mM KH2PO4, 0.9 mMMgCl2, pH 7.4). The platelet sus-
pension was then applied to a chromatography column containing 5 ml
packed Sepharose 2B‐300, previously equilibrated with JNL buffer. The
platelet concentration was determined using a Sysmex‐100 particle
counter (Sysmex, Kobe, Japan).
Static platelet adhesion assay was performed as described previ-
ously (Kerrigan et al., 2002). Briefly, 96‐well plates were coated with
bacteria (1 × 109 cells ml−1), recombinant protein fragments,
fibrinogen, or BSA (each at 100 μg ml−1). Gel‐filtered platelets
(4 × 108 cells ml−1) were added to each well and incubated for
45 min at 37°C. Following a gentle wash to remove unattached plate-
lets, lysis buffer containing p‐nitrophenol phosphate was added to the
wells and incubated for 20 min at 37°C. The resultant absorbance at
405 nm (A405) was a measure of acid phosphatase activity, propor-
tional to numbers of platelets bound. Where appropriate, platelets
were activated with 20 μM TRAP sequence SFLLRN (Sigma Aldrich,
Wexford, Ireland).
4.11 | Platelet spreading assay
Poly‐L‐lysine‐coated glass slides were coated with PadA protein
fragment (100 μg ml−1) for 16 hr at 4°C. Slides were then blocked with
1% BSA; washed and gel‐filtered platelets (5 × 106 platelets ml−1) were
allowed to spread on the PadA fragments for 45 min at 37°C. The
slides were washed, the platelets were fixed and permeabilized, and
then the samples were stained with Alexa 546 phalloidin and examined
by confocal microscopy as described in detail elsewhere (Keane et al.,
2013). The percentage of platelets spread was calculated from five
areas, selected randomly, containing 200 or more total cells.
4.12 | Bacterial cell adhesion assays
Extracellular matrix proteins in coating buffer (20 mM Na2CO3, 2 mM
NaHCO3, pH 9.3) were added to the wells of a high‐binding 96‐well
plate (Immulon 2HB) and incubated for 16 hr at 4°C. In some experi-
ments, immobilized substrata were then desialylated with 0.001 U
neuraminidase from Clostridium perfringens (Sigma) in 0.1 M sodium
acetate buffer (pH 5.0) containing 2 mM CaCl2, for 2 hr at 37°C. Wells
were washed once in TBSC (10 mM Tris–HCl pH 7.6, 0.15 M NaCl,
5 mM CaCl2), and non‐specific binding sites blocked with 3% BSA in
TBSC containing 0.05% Tween‐20 (TBST) for 1 hr at 37°C. Bacterial
cultures were grown for 16 hr at 37°C, and cells were harvested by
centrifugation (5000 × g, 7 min). Cells were washed once in TBSC,
adjusted to OD600 0.5, and portions (0.1 ml) incubated with the
immobilized proteins at 37°C for 2 hr. The suspensions were then
removed, and the wells were washed twice in TBS. Adherent cells
were fixed with 25% formaldehyde for 30 min at room temperature.
Wells were washed twice in TBS, 0.5% crystal violet was added, and
the plates were incubated for 2 min at room temperature. Wells were
washed three times in TBS, 10% acetic acid (0.1 ml) was added and
after 5 min, levels of adhesion were quantified by measuring absor-
bance at 595 nm (A595). Previous work has shown that bacterial cell
numbers are proportional to A595 over the range employed in the
assays (Jakubovics et al., 2005).
4.13 | Salivary pellicle adhesion assay
Saliva was collected from at least six healthy adult human subjects,
who provided written informed consent (approved by the National
Research Ethics Committee South Central Oxford C. 165 # 08/
H0606/87 + 5). Exclusion criteria were: antimicrobial medication
within 7 days previously, continuous medication, gross dental caries,
or unstable periodontal disease. Samples were pooled, mixed with
0.25 M dithiothreitol on ice for 10 min and clarified by centrifugation
(8000 × g, 10 min). The supernatant was diluted to 10% with sterile
water, filter sterilized (0.22 μm pore membrane) and aliquots were
stored at −20°C.
Saliva‐coated cover slips were prepared by placing sterile 19‐
mm‐diameter cover slips (Menzel‐Glaser, Braunschweig, Germany)
into 12‐well plates (Greiner) and adding 10% saliva (1 ml) to each
well. The cover slips were incubated at 4°C for 16 hr, washed with
PBS, and transferred to a fresh 12‐well plate. Bacterial cell suspen-
sion (OD600 0.5) was added to each well as described above,
incubated at 37°C for 2 hr, and aspirated from the wells, and the
cover slips were washed twice in TBSC. Adherent cells were fixed
and stained with crystal violet, and levels of adhesion were quanti-
fied by A595 measurement.
4.14 | Biofilm formation
Bacterial cultures grown for 16 hr (10 ml) were harvested by centrifu-
gation (5000 × g, 7 min), washed in modified C (mC) medium (0.25%
Difco Proteose Peptone #2, 0.75% yeast extract, 10 mM K2HPO4,
0.4 mM MgSO4.7H2O, 17 mM NaCl, pH 7.5, containing 0.2% glucose)
and adjusted to OD600 1.0 in mC medium. Saliva‐coated cover slips
were prepared as above in 12‐well plates (Greiner) before bacterial cell
suspension (OD600 0.5) was added to each well. The plates were incu-
bated at 37°C for 1 hr with shaking at 50 r.p.m. The cell suspensions
were removed and the cover slips washed twice in mC medium. Fresh
mC medium was then added to each well and the plates were
incubated at 37°C for a further 15 hr. Cover slips were then removed,
washed twice in PBS, and stained with crystal violet as described
above.
4.15 | Recombinant protein binding assays
ECM proteins in coating buffer (50 μl) were added to wells of a high‐
binding 96‐well plate (Immulon 2HB) and incubated for 16 hr at 4°C.
Wells were washed once in TBSC and non‐specific binding sites were
blocked with 3% BSA in TBSC for 1 hr at 37°C. Wells were washed
once in TBSC and recombinant protein (0–5 μg) diluted in TBSC was
applied to the wells and incubated for 1 hr at 37°C. Unbound protein
was removed and wells washed once in TBS. Primary antibody diluted
in TBST was added to the wells and incubated for 1 hr at 37°C. Wells
were washed twice in TBST before adding HRP‐linked secondary anti-
body diluted in TBST containing 3%BSAand incubating for 1 hr at 37°C.
Wells were washed once in TBST, twice in TBS, and detection reagent
(0.102 M Na2HPO4, 0.049 M citric acid, 0.012% H2O2, 3.7 mM o‐
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phenylenediamine) was added to wells. Plates were incubated in the
dark for 10 min at room temperature, 0.56MH2SO4 was added to stop
the reactions and A490 measured. x6His‐tagged proteins were detected
using anti‐tetraHis antibody (Qiagen) at 1:1000 dilution and HRP‐con-
jugated anti‐mouse antibody (Dako) at 1:2000 dilution. Fibrinogen was
detected using rabbit anti‐human fibrinogen antibody (Dako) at 1:1000
dilution and HRP‐conjugated swine anti‐rabbit antibody (Dako) at
1:2000 dilution.
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